Possibilities and efficiency of MSC co-transfection for gene therapy

Sina Christoffers,Lisa Seiler,Elena Wiebe,Cornelia Blume

DOI: https://doi.org/10.1186/s13287-024-03757-6

2024-05-25

Stem Cell Research & Therapy

Abstract:Mesenchymal stem/stromal cells (MSCs) are not only capable of self-renewal, trans-differentiation, homing to damaged tissue sites and immunomodulation by secretion of trophic factors but are also easy to isolate and expand. Because of these characteristics, they are used in numerous clinical trials for cell therapy including immune and neurological disorders, diabetes, bone and cartilage diseases and myocardial infarction. However, not all trials have successful outcomes, due to unfavourable microenvironmental factors and the heterogenous nature of MSCs. Therefore, genetic manipulation of MSCs can increase their prospect. Currently, most studies focus on single transfection with one gene. Even though the introduction of more than one gene increases the complexity, it also increases the effectivity as different mechanism are triggered, leading to a synergistic effect. In this review we focus on the methodology and efficiency of co-transfection, as well as the opportunities and pitfalls of these genetically engineered cells for therapy.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

The paper attempts to address the issue of co-transfection methods and their efficiency in mesenchymal stem cells (MSCs) for gene therapy. Specifically:

1. **Challenges of Co-transfection Technology**: Although MSCs have great potential in cell therapy, they are less sensitive to co-transfection techniques, especially compared to cell lines or primary cell types with lower complexity. Therefore, researchers need to find ways to improve the co-transfection efficiency of MSCs.

2. **Heterogeneity and Donor Differences**: MSCs exhibit high heterogeneity, and there are significant differences in transfection efficiency among MSCs from different donors. This makes it more challenging to achieve consistent effects in clinical applications.

3. **Introduction of Multiple Genes**: While single-gene transfection is feasible, introducing multiple genes can enhance therapeutic effects because multiple mechanisms are triggered, producing synergistic effects. However, the technical difficulty of multi-gene co-transfection is higher.

4. **Choosing the Appropriate Transfection Method**: Viral transfection (such as adenovirus, lentivirus, etc.) and non-viral transfection (such as liposome transfection, electroporation, etc.) each have their advantages and disadvantages. Researchers need to evaluate the effectiveness and safety of these methods to determine the most suitable approach for clinical applications.

By systematically discussing these issues, this review aims to provide comprehensive information on co-transfection techniques for MSCs and to guide future research directions.